back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-10-07 20:45 Tx date 2026-10-01 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-123,275
-24,655 vol $5.00 each |
47,682 | |
| Older filings | ||||||
| Filed 2026-09-23 21:42 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-418,411.89
-82,527 vol $5.07 each |
72,337 | |
| Filed 2026-09-23 21:41 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$45,901
+10,456 vol $4.39 each |
154,864 | |
| Filed 2026-09-23 21:40 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$372,505
+116,408 vol $3.20 each |
144,408 | |
| Filed 2026-09-23 21:39 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-45,901.84
-10,456 vol $4.39 each |
255,258 | |
| Filed 2026-09-23 21:38 Tx date 2026-09-18 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-372,505.60
-116,408 vol $3.20 each |
265,714 | |
| Filed 2026-02-02 21:38 Tx date 2026-02-02 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+28,000 vol |
28,000 | |
| Filed 2026-02-02 21:37 Tx date 2026-02-02 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$314,763
+71,700 vol $4.39 each |
382,122 | |
| Filed 2025-03-20 18:16 Tx date 2025-03-18 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$993,350
+310,422 vol $3.20 each |
310,422 | |
| Filed 2025-03-06 16:43 Tx date 2025-02-25 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-06 16:42 Tx date 2025-02-25 |
$ABUS
Arbutus Biopharma Corporation |
Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||